These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 27071734

  • 21. Orofacial granulomatosis successfully treated with mycophenolate mofetil.
    Antonyan AS, Pena-Robichaux V, McHargue CA.
    J Am Acad Dermatol; 2014 Jun; 70(6):e137-9. PubMed ID: 24831337
    [No Abstract] [Full Text] [Related]

  • 22. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients.
    Zimmerman AB, Berger EM, Elmariah SB, Soter NA.
    J Am Acad Dermatol; 2012 May; 66(5):767-70. PubMed ID: 21783274
    [Abstract] [Full Text] [Related]

  • 23. Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.
    Dumortier J, Guillaud O, Pittau G, Salandre J, Adham M, Scoazec JY, Boillot O.
    Transplant Proc; 2010 Sep; 42(7):2602-6. PubMed ID: 20832553
    [Abstract] [Full Text] [Related]

  • 24. Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate.
    Levy LL, Urban J, King BA.
    J Am Acad Dermatol; 2015 Sep; 73(3):395-9. PubMed ID: 26194706
    [Abstract] [Full Text] [Related]

  • 25. Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase.
    Kuypers DR, Verleden G, Naesens M, Vanrenterghem Y.
    Clin Pharmacol Ther; 2005 Jul; 78(1):81-8. PubMed ID: 16003296
    [Abstract] [Full Text] [Related]

  • 26. Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up.
    Furusawa A, Wakiguchi H, Okazaki F, Korenaga Y, Azuma Y, Yasudo H, Hasegawa S.
    Int J Rheum Dis; 2022 Jan; 25(1):95-96. PubMed ID: 34866347
    [No Abstract] [Full Text] [Related]

  • 27. EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects.
    Sabbatini M, Capone D, Gallo R, Pisani A, Polichetti G, Tarantino G, Gentile A, Rotaia E, Federico S.
    Fundam Clin Pharmacol; 2009 Oct; 23(5):617-24. PubMed ID: 19656208
    [Abstract] [Full Text] [Related]

  • 28. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 29. Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.
    Hardinger KL, Brennan DC, Lowell J, Schnitzler MA.
    Transpl Int; 2004 Nov; 17(10):609-16. PubMed ID: 15517170
    [Abstract] [Full Text] [Related]

  • 30. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.
    Vanthuyne M, Blockmans D, Westhovens R, Roufosse F, Cogan E, Coche E, Nzeusseu Toukap A, Depresseux G, Houssiau FA.
    Clin Exp Rheumatol; 2007 Nov; 25(2):287-92. PubMed ID: 17543155
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1926-30. PubMed ID: 17989103
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
    Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM.
    Arthritis Res Ther; 2015 Apr 03; 17(1):92. PubMed ID: 25890338
    [Abstract] [Full Text] [Related]

  • 33. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL, US Tacrolimus Ointment Study Group.
    Pediatrics; 2008 Dec 03; 122(6):e1210-8. PubMed ID: 19015204
    [Abstract] [Full Text] [Related]

  • 34. Polyoma virus-associated progressive multifocal leukoencephalopathy after renal transplantation: regression following withdrawal of mycophenolate mofetil.
    Weber SC, Uhlenberg B, Raile K, Querfeld U, Müller D.
    Pediatr Transplant; 2011 Mar 03; 15(2):E19-24. PubMed ID: 20880091
    [Abstract] [Full Text] [Related]

  • 35. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S, Pauser S, Sticherling M, Frieling U, Loske KD, Frosch PJ, Haase I, Luger TA.
    Dermatology; 2009 Mar 03; 219(2):126-32. PubMed ID: 19546522
    [Abstract] [Full Text] [Related]

  • 36. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
    Sollinger HW, Sundberg AK, Leverson G, Voss BJ, Pirsch JD.
    Transplantation; 2010 Feb 27; 89(4):446-51. PubMed ID: 20177347
    [Abstract] [Full Text] [Related]

  • 37. Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus.
    Riskalla MM, Somers EC, Fatica RA, McCune WJ.
    J Rheumatol; 2003 Jul 27; 30(7):1508-12. PubMed ID: 12858449
    [Abstract] [Full Text] [Related]

  • 38. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
    Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS.
    J Eur Acad Dermatol Venereol; 2015 Oct 27; 29(10):1905-12. PubMed ID: 25752497
    [Abstract] [Full Text] [Related]

  • 39. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep 27; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 40. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM, Tse KC, Tang CS, Mok MY, Li FK, Hong Kong Nephrology Study Group.
    J Am Soc Nephrol; 2005 Apr 27; 16(4):1076-84. PubMed ID: 15728784
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.